Spots Global Cancer Trial Database for Prediction of Abdominal Complications After GastroEnterological Surgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prediction of Abdominal Complications After GastroEnterological Surgery
Official Title: Abdominal Infectious Complications After Gastrointestinal Surgery in China: a Multi-centered Prospective Registry
Study ID: NCT03828266
Interventions
Study Description
Brief Summary: The aim of this multi-centered study is to understand the epidemiology of infectious complications after gastrointestinal surgery in China. In total, 17 centers from China will prospectively register their patients undergo gastric or colorectal surgeries. Patient demographic data, operation information, and postoperative data including the infectious complications and the outcomes will be registered. We expect to include 2000 gastric and 2000 colorectal patients within one year and the study is expected to be finished in 2020.
Detailed Description: All participating hospital will log in on a website based e-CRF system. Researchers need to register the patient information that three time-points: admission, after surgery, after discharge. The detailed registered information includes: I. Basic and surgical information: Age, height, weight, history of abdominal surgery, ASA score, surgical procedure, extent of lymph node dissection, extent of resection, time of surgery, amount of bleeding, whether it is emergency surgery, whether it is combined with organ resection, whether it is palliative resection, whether combined with preoperative treatment, whether combined with preoperative infection and intraoperative complications. II. Postoperative information: Primary lesion histological type, margin, pathological stage (pTNM); other complications, postoperative death and discharge time, CRP, PCT, WBC levels. III. Abdominal Infection information: Abdominal infection (Y/N), anastomotic leakage (Y/N), intervention, outcome.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Peking University Cancer Hospital, Beijing, Beijing, China
Fujian Medical University Union Hospital, Fuzhou, Fujian, China
Xiamen University First Hospital, Xiamen, Fujian, China
Guangdong People's Hospital, Guangzhou, Guangdong, China
The First Affilliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
South Hospital, Guanzhou, Guangdong, China
Nanchang University First Hospital, Nanchang, Jiangxi, China
Jilin University Second Hospital, Changchun, Jilin, China
Dalian Medical University First Hospital, Dalian, Liaoning, China
Qinghai University Affiliated Hospital, Xining, Qinghai, China
Shandong Provincial Hospital, Jinan, Shandong, China
Qingdao University Affiliated Hospital, Qingdao, Shandong, China
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Huashan Hospital, Shanghai, Shanghai, China
Ruijin Hospital, Shanghai, Shanghai, China
Zhongshan Hospital, Shanghai, Shanghai, China
Xi'an Jiao Tong University First Hospital, Xi'an, Shanxi, China
Hangzhou First Hospital, Hangzhou, Zhejiang, China
Run Run Shaw Hospital, Hangzhou, Zhejiang, China
Contact Details
Name: Ziyu Li, MD PhD
Affiliation: Peking University Cancer Hospital & Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
